Effect of silymarin on liver size and nonalcoholic fatty liver disease in morbidly obese patients A randomized double-blind clinical trial

• Published in: Journal of research in medical sciences Vol. 27; no. 1; p. 76
• Main Authors: Atarodi, Hamed, Pazouki, Abdolreza, Gholizadeh, Barmak, Karami, Reza, Kabir, Ali, Sadri, Ghazal, Kassir, Radwan, Kermansaravi, Mohammad
• Format: Journal Article
• Language: English
• Published: India Wolters Kluwer - Medknow 01.01.2022; Wolters Kluwer Medknow Publications
• Subjects: clinical trial; liver size; morbid obesity; nonalcoholic fatty liver disease; Original; silymarin; ultrasound

Background: A large liver size is a factor that may increase the difficulty of bariatric surgery (BS) and unwanted complications. Some agents have been used to decrease the liver size before BS. Silymarin has been used as an antioxidant agent to improve liver function tests. This study was designed...